바로가기  >

[Abstract]
PURPOSE:

To investigate the potential of low-dose cyclophosphamide (LD-CTX) and anti-CD25 antibody to prevent activation of regulatory T cells (Tregs) during radiation therapy.

METHODS AND MATERIALS:

We used LD-CTX and anti-CD25 monoclonal antibody as a means to inhibit Tregs and improve the therapeutic effect of radiation in a mouse model of lung and colon cancer. Mice were irradiated on the tumor mass of the right leg and treated with LD-CTX and anti-CD25 antibody once per week for 3 weeks.

RESULTS:

Combined treatment of LD-CTX or anti-CD25 antibody with radiation significantly decreased Tregs in the spleen and tumor compared with control and irradiation only in both lung and colon cancer. Combinatorial treatments resulted in a significant increase in the effector T cells, longer survival rate, and suppressed irradiated and distal nonirradiated tumor growth. Specifically, the combinatorial treatment of LD-CTX with radiation resulted in outstanding regression of local and distant tumors in colon cancer, and almost all mice in this group survived until the end of the study.

CONCLUSIONS:

Our results suggest that Treg depletion strategies may enhance radiation-mediated antitumor immunity and further improve outcomes after radiation therapy.

Copyright © 2015 Elsevier Inc. All rights reserved.

[Author information]

Son CH1, Bae JH2, Shin DY3, Lee HR3, Jo WS3, Yang K3, Park YS4.

1Dongnam Institute of Radiological and Medical Sciences, Busan, Korea; Department of Biochemistry, Pusan National University School of Medicine, Yangsan, Korea.
2Department of Biochemistry, Pusan National University School of Medicine, Yangsan, Korea.
3Dongnam Institute of Radiological and Medical Sciences, Busan, Korea.
4Dongnam Institute of Radiological and Medical Sciences, Busan, Korea. Electronic address: biotek01@hanmail.net.
​